Lymed Tablet is a combination pharmaceutical formulation containing Trypsin Chymotrypsin (50000 AU), Bromelain (90 mg), Rutoside (100 mg), and Papain (60 mg), designed to provide potent anti-inflammatory, proteolytic, and antioxidant effects. Trypsin Chymotrypsin, a mixture of proteolytic enzymes, facilitates the breakdown of proteins, thereby reducing inflammation and promoting the resolution of edema and hematoma in various inflammatory conditions. Bromelain, a protease derived from pineapple stems, enhances the anti-inflammatory response and aids in the modulation of immune function, contributing to pain relief and accelerated tissue repair. Rutoside, a bioflavonoid with strong antioxidant properties, strengthens capillary walls and improves microcirculation, which helps in reducing vascular permeability and preventing oxidative damage. Papain, another proteolytic enzyme extracted from papaya, supports the degradation of necrotic tissue and facilitates wound healing. Collectively, these components act synergistically to alleviate symptoms associated with acute and chronic inflammatory disorders, including musculoskeletal injuries, post-surgical swelling, and soft tissue trauma. Lymed Tablet is indicated for use as an adjunct therapy to conventional treatment modalities, promoting faster recovery and enhancing patient comfort. It should be administered under medical supervision, considering contraindications and potential hypersensitivity reactions.